The molecular mechanisms behind activation of FLT3 in acute myeloid leukemia and resistance to therapy by selective inhibitors
Author:
Funder
Cancerfonden
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference88 articles.
1. Targeting FLT3 mutations in AML: review of current knowledge and evidence;Daver;Leukemia,2019
2. FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm;Daver;Blood Cancer J.,2021
3. FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myeloid leukemia;Novatcheva;Clin. Lymphoma Myeloma Leuk.,2021
4. Pattern and dynamics of FLT3 duplications;Todde;J. Chem. Inf. Model.,2020
5. Treatment of acute myeloid leukemia in children: a practical perspective;Egan;Pediatr. Blood Cancer,2021
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment;Current Medicinal Chemistry;2024-09
2. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09
3. Adaptive resistance to FLT3 inhibitors is potentiated by ROS-driven DNA repair signalling;2024-07-26
4. Beyond IC50- A computational dynamic model of drug resistance in enzyme inhibition treatment;2024-03-26
5. Landscape of FLT3 Variations Associated with Structural and Functional Impact on Acute Myeloid Leukemia: A Computational Study;International Journal of Molecular Sciences;2024-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3